Neuroprotective agents for the treatment of acute ischemic stroke.
about
Neuroprotection for ischemic stroke: past, present and futureNeuroprotection for stroke: current status and future perspectivesMolecular mechanisms in the pathogenesis and treatment of acute ischemic strokeFluoxetine-induced cortical adult neurogenesis.Neuroprotection in experimental stroke with targeted neurotrophins.Neuroprotective therapies after perinatal hypoxic-ischemic brain injury.Spectral Doppler optical coherence tomography imaging of localized ischemic stroke in a mouse modelThe ischemic penumbra: correlates in imaging and implications for treatment of ischemic stroke. The Johann Jacob Wepfer award 2011.Antenatal magnesium individual participant data international collaboration: assessing the benefits for babies using the best level of evidence (AMICABLE).Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral arteryMagnesium: potential roles in neurovascular diseaseA new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of strokeInvestigational therapies for ischemic stroke: neuroprotection and neurorecovery.Ischaemic preconditioning: therapeutic implications for stroke?The 2012 Feinberg Lecture: treatment swift and treatment sure.Drug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic moleculesAssociation of serum bilirubin with ischemic stroke outcomes.Targeting the brain: neuroprotection and neurorestoration in ischemic stroke.An overview of therapies to promote repair of the brain after stroke.The role of glutamate in neuronal ischemic injury: the role of spark in fire.Neuroprotection for ischaemic stroke: translation from the bench to the bedside.Emerging neuroprotective drugs for the treatment of acute ischaemic stroke.Transient ischemic attack and stroke in systemic lupus erythematosus.Cerebral tissue repair and atrophy after embolic stroke in rat: a magnetic resonance imaging study of erythropoietin therapy.AS601245, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils.Effects of medullary administration of a nitric oxide precursor on cardiovascular responses and neurotransmission during static exercise following ischemic stroke.Magnesium sulfate treatment decreases the initial brain damage alterations produced after perinatal asphyxia in fetal lambs.A cerebroprotective dose of intravenous citrate/sorbitol-stabilized dehydroascorbic acid is correlated with increased cerebral ascorbic acid and inhibited lipid peroxidation after murine reperfused stroke.Neuroprotective effect of epidermal growth factor plus growth hormone-releasing peptide-6 resembles hypothermia in experimental stroke.Potential application value of xenon in stroke treatment
P2860
Q24645185-0684081D-58EB-4385-96EB-DB5E65902AA5Q26853031-5CB5ECB2-CF71-460A-8C7C-504704DB399AQ28189505-BB633D3E-1983-48A1-9E97-4C961C4C6D70Q30455073-CB4EDB7F-4557-4EE6-ADB5-2D0E4CCE1F3FQ33569623-C2071B5A-CB86-4BEC-B2A6-5212B90E0A79Q33772042-423F28BD-0347-448A-9688-547EB3B22C22Q33783726-1F4094DC-C8C3-4846-8E7B-ED3E9631FF5DQ34020415-175A828C-0E8F-49E5-80A0-66EC25E647CCQ34269738-646FE98A-EB3D-4D8F-BB05-A97D61F8B8F3Q34480959-2EFD6157-D1F0-4BD8-91F9-3393D025118EQ35159997-FAB0E53E-A16D-4B69-AE00-BB8D4FA36542Q35588323-F36CE49F-F4EB-49D4-B218-AEAB111B32BEQ35648103-E3AA90DF-6EB0-404E-B98C-6DD58946A254Q35753366-35987F25-5A0F-4956-9939-146F5393235FQ36488015-78912979-24C7-469A-AAEC-DF65E0DBA1C4Q36841904-522E38CC-BBFE-4B84-9C60-AE49B743E8D7Q37317798-0F5B69B1-0600-4F02-BF01-19558372394AQ37767423-9257EFE7-20D0-4F9E-9AF5-5E3EA27A6316Q37929081-544EF0B9-47A4-4FC2-AA4F-4CC2A95A3822Q37951747-2C1F183B-F8DD-4BBC-BA04-44974CC51CF7Q37991061-869436E7-C502-46B9-9E17-500A8EA03F70Q38100263-18AC63D7-9361-49EF-A2A0-40094898C442Q38149851-E358CF87-71FE-4F97-96C4-2CAB0DE46815Q42083058-3604C8FA-F75A-4CC0-9AF0-6FA7E3A3AB70Q42952149-62EEAF85-872B-47B5-B72C-F5222B335D8FQ45356918-67FC40A1-3D0B-4F19-806E-2106071831F4Q48153446-EE3851DB-F611-4989-A48F-854F060B95D8Q48457018-8B92C0D1-0C0E-413A-B73D-BBBD7DCDE19BQ48464373-F5E405A4-0D8A-4FF2-8404-D729FCBAEAC7Q57492270-EB5DA73F-2060-4F99-BAEA-A88C70B39AF9
P2860
Neuroprotective agents for the treatment of acute ischemic stroke.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Neuroprotective agents for the treatment of acute ischemic stroke.
@ast
Neuroprotective agents for the treatment of acute ischemic stroke.
@en
type
label
Neuroprotective agents for the treatment of acute ischemic stroke.
@ast
Neuroprotective agents for the treatment of acute ischemic stroke.
@en
prefLabel
Neuroprotective agents for the treatment of acute ischemic stroke.
@ast
Neuroprotective agents for the treatment of acute ischemic stroke.
@en
P2093
P2860
P1476
Neuroprotective agents for the treatment of acute ischemic stroke.
@en
P2093
Chelsea S Kidwell
Jeffrey L Saver
Sidney Starkman
P2860
P2888
P356
10.1007/S11910-003-0031-Z
P577
2003-01-01T00:00:00Z